期刊文献+

加替沙星在肾损害大鼠组织分布特性 被引量:1

Study on Tissues Distribution of Gatifloxacin in Injured Kidney of Rats
下载PDF
导出
摘要 目的:建立加替沙星的反相高效液相色谱方法,并对其肾损害模型大鼠体内过程进行分析研究。方法:正常和肾损害造模大鼠ig 20 mg·kg-1加替沙星后5,15 min和4 h测定各组织药物浓度,并收集尿液、胆汁与粪便,测定累积排泄率。结果:正常和肾损害造模大鼠ig20 mg·kg-1加替沙星后5,15 min和4 h,快速分布在各组织中,其中肝、肾、小肠、胃分布最多,大脑未测到药物。正常组与肾损害组大鼠ig 20 mg·kg-1加替沙星后48 h,尿液、胆汁与粪便药物累积排泄率分别为(66.2±8.8)%与(71.2±13.6)%,(8.05±3.08)%与(1.62±O.67)%和(3.63±1.65)%与(3.92±1.87)%。结论:加替沙星在肾损害模型大鼠组织分布和尿液的排泄受到影响,通过了解其体内过程,可为临床应用提供参考。 Objective: To establish RP-HPLC method for determination of the gatifloxaein, and study in vivo tissues distribution of gatifloxaein in injured kidney of rats. Method: After a single of 20 mg·kg^-1 gatifloxacin was given to rats of normal and injured kidney by i. g,drug concentrations of tissues and accumulative excretions of the urinary, bile and dejection were determined by HPLC at 5 min, 15 min and 4 h. Result: The gatifloxaein was distributed rapidly and extensively to all tissues, especially in liver, intestine, stomach and kidney, but not determined in the brain. The accumulative excretions of he urinary, bile and dejection in normal and injured rats were (66.2±8.8)% and (30.6±12.0)%, (8.05 ±3.08)% and (12.68±6.67)%, (3.63±1.65)% and (8.22 ±3.00) %, respectively. Conclusion: The gatifloxaein was influenced in tissues distribution and excretions of the urinary by injured kidney in rats. It can be offer the reference for the clinical application.
出处 《中国药师》 CAS 2006年第10期894-897,共4页 China Pharmacist
基金 广西自然科学基金资助(编号0249016)
关键词 加替沙星 组织分布 肾损害 反相高效液相色谱法 大鼠 Gatifloxacin Tissues distribution Injured kidney RP-HPLC Rat
  • 相关文献

参考文献6

二级参考文献12

  • 1Perry CM, Balfour JAB, Lamb HM. Catifloxacin[J]. Drugs, 1999,58(4):683.
  • 2Stahlberg H J, Cohler K, Cuillane M, et al. Effeets of gatifloxacin mesylate(GTFX) on the pharmacokinetics of theophyline in heathly young volunteers [J]. Antimierob Agents Chemther, 1999,44(sup A):136.
  • 3Lubasch A, Keller I, Borner K,et al. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers.J Anthmicrob Agents Chemother,2000,44(10) :2600
  • 4Naber CK, Steghafner M, Kingig-Schippers M, et al. Concentrations of gatifloxacin mesylate in plasma and urine and penetrition into prostatic and seminal fluid,ejaculate,and sperm cells after single oral administrations of 400 milligrams to volunteers. J Anthmicrob Agents Chemother,2001,45 (1) :293
  • 5Nakashima M, Uematsu T, Kosuge K,et al. Single - and multiple -dose pharmacokinetics of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone, in humans. J Antimicrob Agents Chemother, 1995, 39(12) :2635
  • 6Stahlberg H J, Gohler K, Guillane M,et al. Effects of gatifloxacin mesylate ( GTFX ) on the pharmacokinetics of theophyline in heathly young volunteers [ abstract]. J Antimicrob Agents Chemther, 1999,44(suppl A) :136
  • 7Perry CM, Balfour JAB, Lamb HM. Gatifloxacin. Drugs, 1999, 58(4) :683
  • 8Hosaka M,Yasue T,Fukuda H,et al. In vitro and in vivo antibacterial activities of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone. J Antimicrob Agents Chemother, 1992,36 ( l0 ) :2108
  • 9孙涛,宋坤改,林赴田.盐酸加替沙星的药代动力学研究[J].中国新药杂志,2000,9(11):758-761. 被引量:35
  • 10邓立东,程强,徐勤.HPLC法测定加替沙星血药浓度[J].华夏医学,2002,15(2):159-160. 被引量:6

共引文献56

同被引文献11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部